If the charts are to be believed, the path of least resistance for these 4 stocks should be higher.
The stocks are Biogen, Regeneron, Celgene and Gildead, known on "Mad Money" as Jim Cramer's "4 horsemen of biotech." Although fundamentals have appeared bullish to Cramer for quite some time, he often turns to technicals for further insights.
And according to analysis from Bob Lang, a top analyst and senior strategist at ExplosiveOptions.net, all of Cramer's 4 horsemen look like they could gallop a lot higher.
Here's the breakdown.